BCL2 and neoplasm: The mechanism is based on the induction of apoptosis in tumor cells by altering the expression levels of pro/antiapoptosis-related genes (e.g., p53, Bcl-2, caspase) and even reducing the dose of cisplatin, which could help to decrease the associated systemic toxicity [225].